Shoyebo Oluwaseun Gideon* and Jokotola Temiloluwa Priscilla

Department of Veterinary Medicine, University of Ilorin, Nigeria

*Corresponding Author: Shoyebo Oluwaseun Gideon, Department of Veterinary Medicine, University of Ilorin, Nigeria.

Received: August 21, 2023 Published: November 06, 2023

Abstract

Anthrax, a zoonotic infectious disease caused by the bacterium Bacillus anthracis, remains a persistent public health concern in Nigeria. This article delves into the multifaceted aspects of anthrax, exploring its transmission, etiology, clinical manifestations, diagnosis, management, and proposing future recommendations for effective control. Transmission of anthrax primarily occurs through contact with contaminated animal products or spores, often linked to livestock handling and consumption. The etiology section elucidates the unique characteristics of Bacillus anthracis, emphasizing its spore-forming capability, which enables survival in harsh environments and contributes to its virulence. Clinical manifestations of anthrax vary based on the route of exposure, encompassing cutaneous, inhalation, and gastrointestinal forms. Early diagnosis is essential for the right management intervention. The article discusses various diagnostic methods, including laboratory tests and imaging techniques, aiming to improve accuracy and timely intervention. Effective management of anthrax necessitates a multi-faceted approach involving antimicrobial therapy, supportive care, and preventive measures. However, the article underscores the challenges associated with limited resources, inadequate surveillance, and suboptimal healthcare infrastructure in Nigeria. These factors hinder the optimal management of anthrax cases and contribute to its persistence. Looking ahead, this article presents strategic recommendations for addressing anthrax in Nigeria's context. Enhancing public awareness campaigns, strengthening veterinary surveillance, and promoting research collaboration are highlighted as pivotal measures to mitigate the threat of anthrax. By integrating interdisciplinary efforts, health authorities can foster a comprehensive approach to anthrax prevention, diagnosis, and treatment. In conclusion, anthrax remains a formidable public health challenge in Nigeria, driven by its intricate transmission dynamics, diverse clinical presentations, and healthcare system limitations. By addressing these complexities head-on and implementing proactive measures, Nigeria can curtail the impact of anthrax, safeguarding both human and animal populations and paving the way for a healthier future.

Keywords: Anthrax; Health; Concern; Nigeria

References

1. Klemm DM and Klemm WR. “A_history_of_anthrax”. Global Picture of Animal Disease”. JAVMA (1959): 458-462.
2. Elelu N., et al. “Neglected zoonotic diseases in nigeria: Role of the public health veterinarian”. In Pan African Medical Journal (Vol. 32). African Field Epidemiology Network (2019).
3. Dixon IC., et al. “ANTHRAX”. In Review Article Medical Progress MEDICAL PROGRESS 341 (1999): 815-826.
4. Grabenstein JD. “Anthrax vaccine: A review”. In Immunology and Allergy Clinics of North America4 (2003): 713-730.
5. Ikede BO., et al. Severe diffuse haemorrhages were pre-sent in the lungs, epi-and endo-cardium, “ANTHRAX IN CAPTIVE CARNIVORES IN IBADAN, NIGERIA”. In Caracal: 130 Journal of Wildlife Diseases (1976): 12.
6. Jefferson T., et al. “Vaccines for preventing anthrax”. In Cochrane Database of Systematic Reviews. John Wiley and Sons (1998).
7. Kamal SM., et al. “Anthrax: An update”. Asian Pacific Journal of Tropical Biomedicine6 (2011): 496-501.
8. Sweeney DA., et al. “Anthrax infection”. In American Journal of Respiratory and Critical Care Medicine12 (2011): 1333-1341.
9. Adejoro L. “Nigeria at high risk of anthrax outbreak, FG warns (2023).
10. Klinmon DM TD. “A single dose combination therapy that both prevents and treats anthrax infection”. Vaccine (2009): 1811-1815.

Citation

Citation: Shoyebo Oluwaseun Gideon. “Anthrax: A Looming Public Health Concern in Nigeria".Acta Scientific Veterinary Sciences 5.12 (2023): 19-24.

Copyright

Copyright: © 2023 Shoyebo Oluwaseun Gideon. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.